Aktia Bank Plc: Managers’ Transactions – Carola Nilsson

Aktia Pankki Oyj
·1 min read


Aktia Bank Plc
Stock Exchange Release
4 March 2021 at 4.15 p.m.

Aktia Bank Plc: Managers’ Transactions – Carola Nilsson

Person subject to the notification requirement
Name: Nilsson, Carola
Position: Other senior manager
Issuer: Aktia Bank plc
LEI: 743700GC62JLHFBUND16

Notification type: INITIAL NOTIFICATION
Reference number: 743700GC62JLHFBUND16_20210303101625_56

____________________________________________

Transaction date: 2021-03-02
Venue not applicable
Instrument type: SHARE
ISIN: FI4000058870
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Transaction details
(1): Volume: 769 Unit price: 0.00 EUR

Aggregated transactions
(1): Volume: 769 Volume weighted average price: 0.00 EUR

Aktia Bank Plc

Further information:
Ari Syrjäläinen, General Counsel, tel. +358 50 362 9587

Distribution:
Nasdaq Helsinki Ltd
Mass media
www.aktia.com

Aktia is a Finnish asset manager, bank and life insurer that has been creating wealth and wellbeing from one generation to the next for 200 years. We serve our customers in digital channels everywhere and face-to-face in our offices in the Helsinki, Turku, Tampere, Vaasa and Oulu regions. Our award-winning asset management business sells investment funds internationally. We employ approximately 830 people around Finland. Aktia's assets under management (AuM) on 31 December 2020 amounted to EUR 10.4 billion, and the balance sheet total was EUR 10.6 billion. Aktia's shares are listed on Nasdaq Helsinki Ltd (AKTIA). aktia.com.



Latest Stories

  • Bond Yields Rise as U.S. Futures Steady Before CPI: Markets Wrap

    (Bloomberg) -- Bond yields climbed and U.S. futures steadied as traders awaited inflation data, a Treasury auction and corporate earnings to assess the market outlook. Bitcoin hit a record.The yield on the 10-year U.S. benchmark headed back toward 1.7%, with rates across Europe rising in sympathy. Gains in European shares were led by tech shares, while most U.S. stock futures were little changed.Tuesday’s U.S. consumer-price data is being closely watched as the Federal Reserve has signaled it’s prepared to let the economy run hot to guide the rebound from the pandemic. Although policymakers at the U.S. central bank expect a bump in consumer prices to be short-lived, faster CPI threatens not only bonds but stocks with long-term horizons such as tech.“A jump in U.S. CPI today is well flagged, but it should be a wake up call to what we think will be stickier inflation in the coming months, if not years,” strategists at ING Groep NV including Padhraic Garvey wrote in a client note. “This would render the Fed’s position increasingly stretched.”“Policy-sensitive” five-year securities way be most vulnerable to a deeper selloff, according to the ING strategists. The Treasury plans to auction 30-year bonds Tuesday after sales of three- and 10-year notes attracted decent demand Monday.Meanwhile, Bitcoin jumped to an all-time high as the mood in cryptocurrencies turned bullish before Coinbase Global Inc. goes public. Oil rose toward $60 a barrel.Some key events to watch this week:Banks and financial firms begin reporting first-quarter earnings, including JPMorgan Chase & Co., Citigroup Inc., Bank of America Corp., Morgan Stanley, Goldman Sachs Group Inc.The U.S. releases inflation data Tuesday.Economic Club of Washington hosts Fed Chair Jerome Powell for a moderated Q&A on Wednesday.U.S. Federal Reserve releases Beige Book on Wednesday.U.S. data including initial jobless claims, industrial production and retail sales come Thursday.China economic growth, industrial production and retail sales figures are on Friday.These are some of the main moves in financial markets:StocksFutures on the S&P 500 Index were little changed at 9:40 a.m. London time.The Stoxx Europe 600 Index rose 0.2%.The MSCI Asia Pacific Index gained 0.2%.The MSCI Emerging Market Index was little changed.CurrenciesThe Bloomberg Dollar Spot Index was little changed.The euro sank 0.1% to $1.1898.The British pound rose 0.1% to $1.375.The onshore yuan was little changed at 6.548 per dollar.The Japanese yen was little changed at 109.34 per dollar.BondsThe yield on 10-year Treasuries jumped two basis points to 1.69%.The yield on two-year Treasuries gained one basis point to 0.17%.Germany’s 10-year yield rose one basis point to -0.29%.Japan’s 10-year yield decreased less than one basis point to 0.107%.Britain’s 10-year yield increased one basis point to 0.795%.CommoditiesWest Texas Intermediate crude climbed 0.2% to $59.82 a barrel.Brent crude increased 0.3% to $63.46 a barrel.Gold weakened 0.3% to $1,727.52 an ounce.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Women are loving these £49.50 Joules chinos: 'Best trousers I own'

    Elevate any casual outfit or pair with a simple T-shirt for a relaxed picnic look.

  • Air France-KLM prices capital hike at 4.84 euros per share

    Air France-KLM on Tuesday launched a capital hike at 4.84 euros ($5.76) per share as part of a 4 billion-euro recapitalisation to shore up its finances amid the COVID-19 crisis. The airline said in a statement it could raise up to 1.036 billion euros if demand was sufficient to exercise an option to increase the size of the rights issue. Shares of the Franco-Dutch company were down 4.33% at 5.08 euros at 0810 GMT, the worst performer on France's French SBF 120 index.

  • UnionPay Announces Partnership with Splitit to Bring Flexibility and Simplicity to Payments

    UnionPay International (UPI) has announced its partnership with Splitit, a leading global monthly installment payments solution provider, bringing the industry-leading Buy Now Pay Later (BNPL) services to 8.1 billion UnionPay cardholders with a flexible, interest-and fee-free payments option.

  • Apple event: Mysterious launch next week revealed by Siri

    Apple will hold a major launch event next week, according to its own Siri digital assistant. The event is yet to be officially revealed but asking the voice assistant for information on the next Apple gave information about when it would occur. “The special event is on Tuesday, April 20 at Apple Park in Cupertino, CA,” the message read.

  • Taiwan: 'Record number' of China jets enter air zone

    Beijing sends 25 military aircraft into Taiwan as the US warns against an 'increasingly aggressive' China.

  • Decisions of Aspocomp Group Plc's Annual General Meeting 2021 and Board of Directors' organization meeting

    Aspocomp Group Plc, Company Announcement, April 13, 2021 at 11:40 a.m. DECISIONS OF THE ANNUAL GENERAL MEETING 2021 The Annual General Meeting of Aspocomp Group Plc held on April 13, 2021 adopted the annual accounts and the consolidated annual accounts as well as granted the members of the Board of Directors and the CEO discharge from liability regarding the financial period 2020. The Annual General Meeting approved the Remuneration Report for the governing bodies 2020. In accordance with the proposal of the Board of Directors, the Annual General Meeting decided to authorize the Board of Directors to decide, at its discretion, on the distribution of up to EUR 0.07 per share from retained earnings and / or return on invested equity in one or more tranches. The authorization is valid until the beginning of the next Annual General Meeting. The company will publish any Board decision on the distribution of funds separately and at the same time confirms the relevant reconciliation and payment dates. The Annual General Meeting decided that no dividend shall be distributed by a decision of the Annual General Meeting. The Annual General Meeting decided to set the number of Board members at four (4) and re-elected the current members of the Board Ms. Päivi Marttila and Ms. Kaarina Muurinen and elected Mr. Jukka Huuskonen and Mr. Anssi Korhonen as new members to the Board, for a term of office ending at the closing of the following Annual General Meeting. The Annual General Meeting re-elected PricewaterhouseCoopers Oy, Authorized Public Accountants, as the company's auditor for a term of office ending at the closing of the following Annual General Meeting. PricewaterhouseCoopers Oy has notified that Mr. Mikko Nieminen, Authorized Public Accountant, will act as its principal auditor. The Annual General Meeting decided that the chairman of the Board of Directors will be paid EUR 30,000, the vice chairman of the Board of Directors be paid EUR 20,000 and the other members will be paid EUR 15,000 each in remuneration for their term of office. The Annual General Meeting further decided that EUR 1,000 will be paid as remuneration per meeting to the chairman and that the other members be paid EUR 500 per meeting of the Board and its committees. The members of the Board of Directors will further be reimbursed for reasonable travel costs. The auditor’s fees will be paid according to the auditor’s invoice. The Annual General Meeting decided to authorize the Board of Directors, in one or more installments, to decide on the issuance of shares and the issuance of options and other special rights entitling to shares referred to in Chapter 10 Section 1 of the Companies Act as follows: The number of shares to be issued based on the authorization may in total amount to a maximum of 684,144 shares. The Board of Directors decides on all the terms and conditions of the issuances of shares and of options and other special rights entitling to shares. The authorization concerns both the issuance of new shares as well as own shares possibly held by the company. The issuance of shares and of options and other special rights entitling to shares referred to in Chapter 10 Section 1 of the Companies Act may be carried out in deviation from the shareholders’ pre-emptive rights (directed issue). The authorization cancels the authorization given by the General Meeting on June 9, 2020 to decide on the issuance of shares as well as the issuance of special rights entitling to shares. The authorization is valid until June 30, 2022. The minutes of the Annual General Meeting are available on the company’s website at www.aspocomp.com/agm starting from April 27, 2021 at the latest. THE BOARD OF DIRECTORS' ORGANIZATION MEETING In its organization meeting held after the Annual General Meeting, the Board of Directors of Aspocomp Group Plc re-elected Ms. Päivi Marttila as Chairman of the Board and Ms. Kaarina Muurinen as Vice Chairman. The Board of Directors did not establish an Audit Committee, the Board itself performs the duties of the Audit Committee. The Board of Directors has at its meeting evaluated the independence of the Board members in compliance with the recommendations of the Finnish Corporate Governance Code. It is the view of the Board of Directors that all Board members are independent of the company's major shareholders. The Board of Directors has also assessed that all the Board members are independent of the company. For further information, please contact Mikko Montonen, President and CEO, tel. +358 40 5011 262, mikko.montonen(at)aspocomp.com. ASPOCOMP GROUP PLC Mikko Montonen President and CEO Aspocomp – heart of your technology A printed circuit board (PCB) is used for electrical interconnection and as a component assembly platform in electronic devices. Aspocomp provides PCB technology design, testing and logistics services over the entire lifecycle of a product. The company’s own production and extensive international partner network guarantee cost-effectiveness and reliable deliveries. Aspocomp’s customers are companies that design and manufacture telecommunication systems and equipment, automotive and industrial electronics, and systems for testing semiconductor components for security technology. The company has customers around the world and most of its net sales are generated by exports. Aspocomp is headquartered in Espoo and its plant is in Oulu, one of Finland’s major technology hubs. www.aspocomp.com

  • Adding Value to "Trash" at IPC's Recycling and Buy Back Centre

    The decluttering, recycling, and upcycling trend has been building steadily since the beginning of the COVID-19 pandemic. Hence, IPC Shopping Centre has established its Recycling and Buy-Back Centre (RBBC) to be a hub for sustainable waste disposal with the expansion of its recyclable range to support the community in their recycling journey.

  • UK lockdown fuels 695% surge in Just Eat orders

    The business said in its quarterly report that it had reached a 695% order growth rate year-on-year in the UK.

  • Seth Meyers Explains Why He's Totally Unsurprised That Trump's Snubbing Matt Gaetz

    The "Late Night" host threw back to the time the former president repeatedly called the lawmaker by the wrong name.

  • David Beckham to Present Disney Plus Series ‘Save Our Squad’

    David Beckham is set to present a new Disney Plus series called “Save Our Squad.” Co-produced by Twenty Twenty and Beckham’s production outfit Studio 99, the series will find the football icon return to East London football pitches where he played as a child. He will mentor a young grassroots side who are struggling to […]

  • Global Genetic Testing Market Report 2021-2025: Newborn, NIPT, Predictive, Oncology, DTC, Others - COVID-19 Crowds Out Other Services

    Dublin, April 13, 2021 (GLOBE NEWSWIRE) -- The "Global Genetic Testing Market Forecasts for Applications and Technologies 2021-2025 - COVID-19 Pandemic Impact Updates with Executive and Consultant Guides" report has been added to ResearchAndMarkets.com's offering. This report forecasts the market size out to 2025. The report includes detailed breakouts for 14 countries and 5 regions. Is genomic cancer testing bouncing back? What has happened to Direct to Consumer testing? Will all newborns receive Whole Genomic Sequencing at birth? The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth. New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry. The traditional genetic testing market is growing in volume and growing in the breadth of tests creating new life, and new problems for the industry. Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years. Key Topics Covered: Genetic Testing - Strategic Situation Analysis & Impact of COVID-19 Pandemic Guide for Executives, Marketing, Sales and Business Development StaffGuide for Management Consultants and Investment Advisors 1. Introduction and Market Definition1.1 Genetic Testing Definition in This Report1.2 The Genomics Revolution 1.3 Market Definition1.3.1 Revenue Market Size1.3.1 Newborn Screening 1.3.2 Non Invasise Pregnancy Testing1.3.3 Predictive1.3.4 Oncology1.3.5 Direct to Consumer1.3.6 Other Application1.3.7 PCR 1.3.4 NGS1.3.5 Cytogenetic1.3.6 Other Technology 1.4 U.S. Medical Market and laboratory Testing - Perspective1.4.1 U.S. Medicare Expenditures for Laboratory Testing 2. Market Overview2.1 Market Participants Play Different Roles2.1.1 Supplier/pharmaceutical 2.1.2 Independent lab specialized/esoteric 2.1.3 Independent lab national/regional2.1.4 Independent lab analytical2.1.5 Public National/regional lab2.1.6 Hospital lab2.1.7 Physician lab 2.1.8 DTC Lab2.1.9 Independent Genetic Testing Lab2.1.10 Audit Body2.2 Genetic Tests -Types, Examples and Discussion 2.2.1 Preimplantation Genetic Diagnosis- An Emerging Market2.2.2 Prenatal Diagnosis - New Technologies Create Opportunity2.2.3 Newborn Screening 2.2.2 Diagnostic Testing 2.2.3 Carrier Testing2.2.6 Predictive and Presymptomatic Testing2.2.7 Pharmacogenomics2.2.8 Forensic Testing2.2.9 Parental Testing2.2.10 Ancestral Testing2.3 Industry Structure2.3.1 Hospital's Testing Share2.3.2 Economies of Scale2.3.2.1 Hospital vs. Central Lab 2.3.3 Physician Office Lab's 2.3.4 Physician's and POCT 2.4 Market Shares of Key Genetics Players - Analysis 3. Market Trends3.1 Factors Driving Growth3.1.1 Genetic Discoveries Creating New Diagnostic Markets3.1.2 Aging Population a Boon for Diagnostics3.1.3 Pharmacogenomics Drives Further Growth. 3.1.4 Oncology and Liquid Biopsy Enter New Era3.1.5 Fertility Practice Growth drives market 3.1.6 Direct to Consumer begins to break out 3.2 Factors Limiting Growth3.2.1 Increased Competition Lowers Price3.2.2 Lower Costs.3.2.3 Testing usage analysis curtailing growth3.2.4 Wellness has a downside3.3 Instrumentation and Automation3.3.1 Instruments Key to Market Share3.3.2 Bioinformatics Plays a Role. 3.4 Diagnostic Technology Development3.4.1 Next Generation Sequencing Fuels a Revolution. 3.4.2 Impact of NGS on pricing 3.4.3 POCT/Self Testing Disruptive Force3.4.4 Pharmacogenomics Blurs Diagnosis and Treatment3.4.5 CGES Testing, A Brave New World3.4.6 Biochips/Giant magneto resistance based assay 4. Genetic Testing Recent Developments Progenity Revenues Fall on COVID-19 EffectNatera Launches Tumor Genomic Profiling Assay23andMe To Go PublicGuardant Health to Offer Tumor Tissue SequencingAncestry Quits Health OfferingDTC Firm MyDNA Merges With Gene by GeneAetna Coverage for NIPT to Include All PregnanciesAgios Pharmaceuticals, PerkinElmer Partner on Hereditary Anemia Genetic TestingTumor, Germline Testing of Cancer Patients Can Give Discordant ResultsInvitae Completes Acquisition of ArcherDxPrenetics Receives $15M InvestmentSanford Health Invests $800K in TruGenomix as Part of PTSD Test AlliancePreconception Carrier Screening Trial Begins in AustraliaGenetic Testing Clinical Use Just BeginningFulgent Genetics Q1 Revenues Jump 44 PercentBlueprint Genetics, NICER Consortium Developing Genetic Test for Immunologic, Hematologic DisordersNatera Terminates Qiagen Agreement for Developing NGS-Based Genetic TestsInvitae Acquires Three Companies: YouScript, Genelex, DiploidPerkinElmer SCID Test Chosen for Newborn Screening Evaluation in EnglandGermline Cancer Risk Mutations Sometimes Reported in Tumor TestingBlueprint Genetics, Archimedlife to Launch Genetic Testing in North AmericaInvitae to Offer No-Charge Genetic Testing to Pancreatic Cancer PatientsPhosphorus Offers DNA Testing to Assess Disease RiskArivale Shuts Down Personalized Wellness BusinessArcherDX Acquires Baby GenesMDxHealth, LifeLabs Ink Distribution Agreement for Prostate Cancer AssayThermo Fisher Purchases 9 Percent Stake in Yourgene HealthInvitae Partners to Expand Free Epilepsy Genetic Testing ProgramIllumina, Chinese Firm Partner on NGS System for Genetic Disease DxNanoString Technologies Prices $103.5M Common Stock OfferingCanine Consumer Genomics Firm Embark Veterinary Raises $10MYourgene Health to Acquire ElucigeneHelix, AdventHealth Partner on Genetic Screening Study 5. Profiles of Key Companies 10. Genomics, Inc23andME IncAbbott DiagnosticsAccuraGen Inc.Adaptive BiotechnologiesAdmera Health, LLCAgena Bioscience, IncAgilentAkonni BiosystemsAncestry.com LLCAnchor DxArcherDx, IncARUP LaboratoriesAsuragenBaylor Miraca Genetics LaboratoriesBeckman Coulter, Inc.Becton, Dickinson and CompanyBGI Genomics Co. LtdBioarray GeneticsBiocept, IncBiodesix IncBioFluidicaBioGenexBiolidics LtdbioMerieux DiagnosticsBioneer CorporationBio-Rad Laboratories, Inc.Bio-TechneCancer GeneticsCaris Molecular DiagnosticsCellMax LifeCentogeneChronix BiomedicalCirculogeneClinical GenomicsColor GenomicsComplete Genomics, Inc. - A BGI CompanyCynvenioDante LabsDatar Cancer Genetics LimitedDiasorin S.p.AEpic SciencesEpigenomics AGEurofins ScientificExcellerate BioscienceExosome DiagnosticsFabric GenomicsFluidigm CorpFoundation MedicineFreenomeFUJIFILM Wako DiagnosticsFujirebioGE Global ResearchGE Healthcare Life SciencesGene by Gene, Ltd.GenedriveGeneFirst Ltd.Genetron Health (Beijing) Co., Ltd.GenewizGenomic HealthGenomics EnglandGenomics Personalized Health (GPH)GenomOncologyGenzyme CorporationGrail, IncGrifolsGuardant HealthGuardiomeHeiScreenHelixHelomicsHologicHorizon DiscoveryHTG Molecular DiagnosticsHuman Longevity, Inc.iCellateIlluminaIncell DxInivataIntegrated DiagnosticsInvitae CorporationInvivoscribeKariusMacrogenMDNA Life SCIENCES, IncMDx HealthMedgenomeMeridian BioscienceMesa BiotechMIODxmiR ScientificMNG LabsMolecular MDNantHealth, Inc.NateraNebula GenomicsNeoGenomicsNew OncologyNovogene Bioinformatics Technology Co., Ltd.Omega BioservicesOncoDNAORIG3N, Inc.Origene TechnologiesOxford Nanopore TechnologiesPacific BiosciencesPanagenePerkin ElmerPersonal Genome DiagnosticsPersonalisPrecipioPrecisionMedPromegaProtagen DiagnosticsQiagen GmbhQuantumdxRegeneronRoche Molecular DiagnosticsRoswell BiotechnologiesSeegeneSequencing.comSiemens Healthineerssimfo GmbHSinglera Genomics IncSkylineDxStratos GenomicsSure Genomics, Inc.SysmexSysmex InosticsTempus Labs, IncThermo Fisher Scientific IncVeritas GeneticsVolition 6. Global Market Size6.1 Global Market by Country 6.2 Global Market by Application6.3 Global Market by Technology 7. Market Sizes by Application7.1 Newborn Testing Market 7.2 NIPT Market 7.3 Predictive Testing Market7.4 Oncology Testing Market7.5 DTC Testing Market7.6 Other Testing Market 8. Global Genetic Testing Market by Technology8.1 PCR Testing Market8.2 NGS Market 8.3 Cytogenetic Testing Market 8.4 Other Testing Market 9. The Future of Genetic Testing For more information about this report visit https://www.researchandmarkets.com/r/bqrmda CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Russia warns U.S. warships to steer clear of Crimea 'for their own good'

    Russia on Tuesday warned the United States to ensure its warships stayed well away from Crimea "for their own good", calling their deployment in the Black Sea a provocation designed to test Russian nerves. Moscow annexed Crimea from Ukraine in 2014 and two U.S. warships are due to arrive in the Black Sea this week amid an escalation in fighting in eastern Ukraine where government forces have battled Russian-backed troops in a conflict Kyiv says has killed 14,000 people. The deployment comes as the West sounds the alarm over what it says is a big and unexplained build-up of Russian forces close to Ukraine's eastern border and in Crimea.

  • Interparfums Acquires New Parisian Headquarters

    The purchase price for what had been the Socialist Party headquarters is 125 million euros.

  • India to approve coronavirus shots green-lit by WHO, others

    India said Tuesday that it will approve the use of all coronavirus vaccines that have been given an emergency nod by the World Health Organization or regulators in the United States, Europe, Britain or Japan. India’s Health Ministry said the decision was aimed at hastening the use of shots made in other countries and expanding the “basket of vaccines” available for domestic use. India had earlier given the nod to the AstraZeneca vaccine made by Serum Institute of India and another one made by the Indian company Bharat Biotech.

  • Sterling weathers vaccine issues, climbs for second day

    Sterling rose for a second day against the dollar and the euro on Tuesday, as analysts said Britain's vaccination drive had not been derailed by its curbing of the use of AstraZeneca's COVID-19 vaccine. The pound lost 1% against the dollar last week as Britain advised alternatives to the Oxford-AstraZeneca vaccine to vaccinate under-30s. Britain has largely depended on the AstraZeneca vaccine so far to immunize more than half of its population.

  • Virtual Clinical Trials Market Size Worth $11.5 Billion By 2028 | CAGR: 5.7%: Grand View Research, Inc.

    The global virtual clinical trials market size is expected to reach USD 11.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.7% from 2021 to 2028. The need for patient diversity clubbed with enhanced data collection in clinical trials is boosting virtual/decentralized clinical trials (DCTs) market growth.

  • A Scot and three Welshmen – A look at Warren Gatland’s Lions coaching staff

    Gregor Townsend, Steve Tandy, Robin McBryde and Neil Jenkins will work with Gatland.

  • Defence giant Babcock International to cut 1,000 jobs in the UK and overseas

    Defence giant Babcock International has laid out plans to cut 1,000 jobs as part of an overhaul of its business as it revealed write-downs of around £1.7bn. Babcock is headquartered in London and has offices, training facilities, dockyards, testing centres and research and development facilities across the country. Babcock is a key supplier to the Ministry of Defence.

  • Warren Gatland names all-new line-up of assistants for Lions’ South Africa tour

    The head coach will be supported by Gregor Townsend, Steve Tandy, Robin McBryde and Neil Jenkins this summer.